The PE Ratio as of June 2026 (TTM) for Jupiter Neurosciences, Inc. (JUNS) is -0.92

According to Jupiter Neurosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.92. This represents a change of -75.98% compared to the average of -3.83 of the last 4 quarters.

Jupiter Neurosciences, Inc. (JUNS) Historical PE Ratio (quarterly & annually)

How has JUNS PE Ratio performed in the past?

The mean historical PE Ratio of Jupiter Neurosciences, Inc. over the last ten years is -37.30. The current -0.92 PE Ratio has changed 146.65% with respect to the historical average. Over the past ten years (40 quarters), JUNS's PE Ratio was at its highest in in the June 2024 quarter at 144.11. The PE Ratio was at its lowest in in the December 2023 quarter at -94.68.

Jupiter Neurosciences, Inc. (JUNS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Jupiter Neurosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jupiter Neurosciences, Inc. (JUNS) Average PE Ratio

How has JUNS PE Ratio performed in the past?

The current PE Ratio of Jupiter Neurosciences, Inc. (JUNS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Jupiter Neurosciences, Inc. (JUNS) PE Ratio vs. Peers

How is JUNS’s PE Ratio compared to its peers?

Jupiter Neurosciences, Inc.’s PE Ratio is less than Skye Bioscience, Inc. (-0.54), greater than Serina Therapeutics, Inc. (-1.04), less than Aligos Therapeutics, Inc. (-0.61), greater than ABVC BioPharma, Inc. (-3.21), greater than X4 Pharmaceuticals, Inc. (-5.07), greater than Kezar Life Sciences, Inc. (-1.18), less than FibroGen, Inc. (0.18), greater than Genenta Science S.p.A. (-5.47), greater than Mersana Therapeutics, Inc. (-2.07), greater than Grace Therapeutics, Inc. (-4.57),

Build a custom stock screener for Jupiter Neurosciences, Inc. (JUNS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jupiter Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jupiter Neurosciences, Inc. (JUNS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jupiter Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.